Boston Harper Lecture: Engineering Immunotherapies for Cancer

Cancer arises from irregular cell growth, but tumors can also grow and metastasize through compromised immune systems. Cancer immunotherapy aims to train the immune system to destroy tumor cells and help it “remember” to attack those cells to prevent relapse. Melody Swartz of the Institute for Molecular Engineering will discuss this innovative and promising approach to tumor treatment, which requires ongoing research into changes in immune regulation in different types of cancer.

To register or find out more information, please click here.

Featured Faculty

Melody A. Swartz is the William B. Ogden Professor of Molecular Engineering. She studies the lymphatic system and aims to understand, modulate, and exploit the complex roles of lymphatic vessels in immunity and pathophysiology, especially in cancer. Her lab aims to develop novel immunotherapeutic approaches to cancer, including vaccines that target lymph nodes. Swartz is a recipient of the MacArthur Fellowship, a Career Award from the National Science Foundation, an Arnold and Mabel Beckman Young Investigator Award, and the Wenner Prize—Switzerland’s largest prize for cancer research.

To learn more about the entire Harper Lecture Series, please visit the UChicago Alumni Association's page.

Questions? Contact alumniassociation@uchicago.edu or 773.702.2150.